Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas
Clinical trial NCT04617002 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04617002
- Sponsor
- Jazz Pharmaceuticals
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.